Assertio ASRT Stock
Assertio Price Chart
Assertio ASRT Financial and Trading Overview
| Assertio stock price | 23.5 USD |
| Previous Close | 0 USD |
| Open | 23.48 USD |
| Bid | 20.19 USD x 100 |
| Ask | 23.5 USD x 100 |
| Day's Range | 23.48 - 23.5 USD |
| 52 Week Range | 8.61 - 23.5 USD |
| Volume | 270.19K USD |
| Avg. Volume | 349.39K USD |
| Market Cap | 151.86M USD |
| Beta (5Y Monthly) | 0.531 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.55 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.43 USD |
ASRT Valuation Measures
| Enterprise Value | 120.61M USD |
| Trailing P/E | N/A |
| Forward P/E | 9.108527 |
| PEG Ratio (5 yr expected) | 0.89 |
| Price/Sales (ttm) | 1.4865329 |
| Price/Book (mrq) | 2.0025566 |
| Enterprise Value/Revenue | 1.181 |
| Enterprise Value/EBITDA | 31.514 |
Trading Information
Assertio Stock Price History
| Beta (5Y Monthly) | 0.531 |
| 52-Week Change | 144.79% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 23.5 USD |
| 52 Week Low | 8.61 USD |
| 50-Day Moving Average | 21.25 USD |
| 200-Day Moving Average | 14.51 USD |
ASRT Share Statistics
| Avg. Volume (3 month) | 349.39K USD |
| Avg. Daily Volume (10-Days) | 340.63K USD |
| Shares Outstanding | 6.46M |
| Float | 6.26M |
| Short Ratio | 0.71 |
| % Held by Insiders | 1.96% |
| % Held by Institutions | 29.28% |
| Shares Short | 334.92K |
| Short % of Float | 5.25% |
| Short % of Shares Outstanding | 5.17% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -34.93% |
| Operating Margin (ttm) | -185.94% |
| Gross Margin | 70.33% |
| EBITDA Margin | 3.74% |
Management Effectiveness
| Return on Assets (ttm) | -5.71% |
| Return on Equity (ttm) | -38.75% |
Income Statement
| Revenue (ttm) | 102.16M USD |
| Revenue Per Share (ttm) | 15.92 USD |
| Quarterly Revenue Growth (yoy) | -62.50% |
| Gross Profit (ttm) | 71.85M USD |
| EBITDA | 3.83M USD |
| Net Income Avi to Common (ttm) | -35690000 USD |
| Diluted EPS (ttm) | -5.55 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 71.57M USD |
| Total Cash Per Share (mrq) | 11.08 USD |
| Total Debt (mrq) | 40.31M USD |
| Total Debt/Equity (mrq) | 53.3 USD |
| Current Ratio (mrq) | 1.822 |
| Book Value Per Share (mrq) | 11.735 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7081000 USD |
| Levered Free Cash Flow (ttm) | 7.75M USD |
Profile of Assertio
| Country | United States |
| State | IL |
| City | Lake Forest |
| Address | 100 South Saunders Road |
| ZIP | 60045 |
| Phone | 224 419 7106 |
| Website | https://www.assertiotx.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 53 |
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.
Q&A For Assertio Stock
What is a current ASRT stock price?
Assertio ASRT stock price today per share is 23.5 USD.
How to purchase Assertio stock?
You can buy ASRT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Assertio?
The stock symbol or ticker of Assertio is ASRT.
Which industry does the Assertio company belong to?
The Assertio industry is Drug Manufacturers - Specialty & Generic.
How many shares does Assertio have in circulation?
The max supply of Assertio shares is 6.46M.
What is Assertio Price to Earnings Ratio (PE Ratio)?
Assertio PE Ratio is now.
What was Assertio earnings per share over the trailing 12 months (TTM)?
Assertio EPS is -5.55 USD over the trailing 12 months.
Which sector does the Assertio company belong to?
The Assertio sector is Healthcare.
Assertio ASRT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}